Target (CBDY) Liabilities and Shareholders Equity (2013 - 2026)

Target (CBDY) reported Liabilities and Shareholders Equity of $6.1 million for Q1 2026, down 8.91% year-over-year from $6.7 million in Q1 2025, and down 1.63% quarter-over-quarter from $6.2 million in Q4 2025.

Target (CBDY) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends

Target (CBDY) has 14 years of Liabilities and Shareholders Equity data on file, last reported at $6.1 million in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $6.1 million, down 8.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.0 million (down 15.88% YoY), and the FY2025 annual result was $6.2 million, down 18.44% from the prior year.
  • Liabilities and Shareholders Equity retreated to $6.1 million in Q1 2026 per CBDY's latest filing, from $6.2 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $10.6 million in Q3 2022 and troughed at $6.1 million in Q1 2026.
  • A 5-year average of $7.6 million and a median of $7.6 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • On a YoY basis, Liabilities and Shareholders Equity climbed as much as 16.86% in 2023 and fell as far as 21.46% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $7.6 million in 2022, then increased by 16.86% to $8.8 million in 2023, then retreated by 14.34% to $7.6 million in 2024, then declined by 18.44% to $6.2 million in 2025, then slipped by 1.63% to $6.1 million in 2026.
  • Business Quant data shows CBDY's Liabilities and Shareholders Equity at $6.1 million in Q1 2026, $6.2 million in Q4 2025, and $6.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Target - - 191,787.00 6.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.08 Mn
Dec 31, 2025 6.18 Mn
Sep 30, 2025 6.20 Mn
Jun 30, 2025 6.59 Mn
Mar 31, 2025 6.67 Mn
Dec 31, 2024 7.57 Mn
Sep 30, 2024 7.59 Mn
Jun 30, 2024 7.94 Mn
Mar 31, 2024 7.07 Mn
Dec 31, 2023 8.84 Mn
Sep 30, 2023 8.33 Mn
Jun 30, 2023 9.02 Mn
Mar 31, 2023 7.69 Mn
Dec 31, 2022 7.57 Mn
Sep 30, 2022 10.60 Mn
Jun 30, 2021 13.58 Mn
Mar 31, 2021 13.89 Mn
Dec 31, 2020 13.04 Mn
Sep 30, 2020 17.25 Mn
Jun 30, 2020 15.81 Mn